Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M
Incyte is dolloping another deal onto its 2024 partnership plate, buying San Diego-based Escient Pharmaceuticals for $750 million. The...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
bottom of page